Plasma lipoprotein (a) levels in Turkish NIDDM patients with and without vascular diabetic complications

Citation
C. Erem et al., Plasma lipoprotein (a) levels in Turkish NIDDM patients with and without vascular diabetic complications, ACT CARDIOL, 54(4), 1999, pp. 203-207
Citations number
35
Categorie Soggetti
Cardiovascular & Respiratory Systems
Journal title
ACTA CARDIOLOGICA
ISSN journal
00015385 → ACNP
Volume
54
Issue
4
Year of publication
1999
Pages
203 - 207
Database
ISI
SICI code
0001-5385(199908)54:4<203:PL(LIT>2.0.ZU;2-E
Abstract
Objective - Plasma concentrations of lipoprotein (a) [Lp(a)], an independen t risk factor for atherosclerosis, were measured in 59 non-insulin-dependen t diabetes mellitus (NIDDM) patients with and without vascular complication s, and 21 non-diabetic healthy subjects. Results - The plasma log I-p(a) levels were found to be significantly incre ased in the NIDDM patients (1.40 +/- 0.36) compared with;che healthy subjec ts (1.02 +/- 0.53; p < 0.05). Plasma Lp(a) levels in NIDDM patients with di abetic vascular complications (1.51 +/- 0.27) were significantly higher tha n those of the NIDDM patients without diabetic vascular complications (1.23 +/- 0.43) and healthy subjects (p < 0.05). There were significant correlat ions between plasma log Lp(a) levels and apolipoprotein B (apo B) in all NI DDM patients (r: 0.68, p < 0.05). No correlation was observed between Lp(a) levels and age, sex, duration of diabetes, fasting blood glucose, haemoglo bin Alc, the mode of treatment, triglycerides, total cholesterol, low-densi ty lipoprotein cholesterol, high-density lipoprotein cholesterol, and apoli poprotein Al levels in all patients. Conclusions - It was concluded that Lp(a) was a risk factor for angiopathy in NIDDM patients and the patients who have a high plasma Lp(a) concentrati on should be kept under strict glycaemic control.